Low Evidence
Research Overview
MOTS-c Research for Metabolic Syndrome
An evidence-based overview of research examining MOTS-c in the context of metabolic syndrome. This page synthesizes findings from peer-reviewed literature.
Research Summary
MOTS-c activates AMPK and improves glucose metabolism in preclinical models. Human observational studies show lower circulating MOTS-c in Type 2 diabetes patients. No interventional trials have tested whether MOTS-c supplementation improves metabolic outcomes.
Referenced Studies
Click any PMID to view the full study on PubMed.
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. MOTS-c has not received regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.